Applications for Health Disparities Committee Research Vice Chair – Deadline November 20, 2018. Click here for more information about the position and application submission.
Register today for the NRG-LU002 Webinar on November 29, 2018 Read more
NRG Oncology Newsletter Vol. 4 2018 is now available Read more
SBRT Considered Safe Treatment Option for Patients with Multiple (2-4) Metastases Read more
Combined therapy including pelvic lymph node radiation provides significant benefit for prostate cancer patients Read more
Radiation therapy outcomes better for African-American prostate cancer patients than Caucasian patients Read more
NRG-RTOG 9813 is the First Study to Identify the Impact of MGMT Gene Expression on Overall Survival for Patients with Anaplastic Glioma Tumors Read more
Short-Term Androgen-Deprivation Therapy with Radiotherapy Improves Survival over Radiotherapy Alone for up to 10 Years among Men with Early Stage Prostate Adenocarcinoma Read more
Patient Reported Outcomes on NRG-RTOG 0232 Indicate Brachytherapy Alone is the Superior Treatment for Men with Intermediate Risk Prostate Cancer Read more
Data Supports Interaction of Pretreatment Immune Inflammatory State of Patient Outcomes following Radiotherapy in High Risk Prostate Cancer Trial Read more
Applications for NRG Oncology Clinical Research Coordinator Mentor Program Now Open Read More
The Addition of a CTLA4 Targeted Therapy to a PD-1 Targeted Therapy Could Benefit Women with Ovarian Cancer Read more
Hurricane Florence Notice: Potential Impact on NRG Oncology Research Read more
Dr. Hudson Appointed to National Research Institute's Advisory Panel Read more
Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer. Read more
Catch up on all the news from the July 2018 NRG Oncology Semiannual Meeting. A special edition newsletter is now posted. Read more
The recording of the NRG Oncology Digital Health and Personal Connected Health Minisymposium is now posted. Read more
NRG Oncology Newsletter Vol. 3 2018 now posted Read more
StereotacticBody Radiation Therapy (SBRT) May be an Effective and Safe Alternative for Patients with Medically Operable Early-Stage Lung Cancer Read more
MGMT Promoter Methylation Associated with Improved Survival for Patients with WHO Grade II Gliomas Read more
An Important Word from Quality Assurance staff about Protocol Amendments Read more
Dr. Chakravarti Selected to Serve on NCI Advisory Board of Scientific Counselors Read more
Dr. Felix Feng Selected as the New NRG Oncology Genitourinary Cancer Committee Chair Read more
Drs. Fisher & Wolmark receive SSO 2018 Charles M. Balch, MD Distinguished Service Award. Read more
NRG Oncology/RTOG 0126: Higher-Dose Radiotherapy Lowers Risk of Recurrence but Does Not Improve Survival for Men with Prostate Cancer Read more